KONEF (KONEF) Stock Price & Analysis
KONEF (KONEF) rose 0.00% to USD 0 as of June 10, 2026 at 14:31 UTC, according to Nexqual real-time market data.
KONEF last closed at USD 0; the session ranged USD 0–0 on volume of 360 shares. Market capitalization is $1,299, with a 52-week range of USD 0–0 (PNK). Source: Nexqual, June 10, 2026 at 14:31 UTC.
Key Statistics (as of June 10, 2026 at 14:31 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 360 shares |
| Market Cap | $1,299 |
| Exchange | PNK |
Technical Analysis (KONEF)
Nexqual's technical model rates KONEF "SELL" based on 0 bullish and 1 bearish signals across 124 daily candles, as of June 10, 2026 at 14:31 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Above (USD 0) |
Analyst Ratings (KONEF)
Wall Street analysts rate KONEF "None", per Nexqual as of June 10, 2026 at 14:31 UTC.
| Consensus Rating | None |
|---|
Earnings (KONEF)
Source: Nexqual, June 10, 2026 at 14:31 UTC.
Financials & Fundamentals (KONEF)
| Total Revenue | $6.44M |
|---|---|
| Revenue Growth (YoY) | +2.60% |
| Gross Margin | +6.59% |
| Operating Margin | -320.82% |
| Profit Margin | +0.00% |
| ROE | -656.27% |
| Current Ratio | 0.26 |
| Total Cash | $315,196 |
| Total Debt | $2.13M |
| Free Cash Flow | $4.46M |
Source: Nexqual, June 10, 2026 at 14:31 UTC.
Financial Health Score (KONEF)
Nexqual rates KONEF's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 14:31 UTC.
| Growth | Mixed — Revenue +2.6% YoY (latest Q), slow |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Mixed — $315K cash vs $2M debt |
| Cash Flow | Strong — FCF $4M, 69% margin |
| Efficiency | Critical — ROE -656%, ROA -79.9% |
Ownership (KONEF)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 129.97M |
| Float | 129.20M |
Source: Nexqual, June 10, 2026 at 14:31 UTC.
Leadership (KONEF)
KONEF is led by Najla Guthrie (age 61), CEO, Chief Research Officer & Director, per Nexqual as of June 10, 2026 at 14:31 UTC.
| CEO, Chief Research Officer & Director | Najla Guthrie (age 61) |
|---|---|
| Chief Financial Officer | Terry Zimaro C.A. (age 50) |
| President of Clinic Operations | Keith White |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BIAFW | bioAffinity Technologies, Inc. | USD 0.16 | ▼ 46.92% |
| TRRI | Trinity Resources Inc. | USD 0 | ▲ 0% |
| UVSS | UNIVERSAL SYSTEM INC WASHINGTON | USD 0 | ▲ 0% |
| MILC | Millennium Sustainable Ventures | USD 0 | ▲ 0% |
| OZYMF | ORPHAZYME A/S | USD 90 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 14:31 UTC. This page is informational and not investment advice.